IPP Bureau
Aster DM Healthcare promoters reduce share pledge from 99% to 41%
By IPP Bureau - March 12, 2025
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
CCRH and Adamas University sign MoU to advance homoeopathy research
By IPP Bureau - March 12, 2025
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
atulya celebrates International Women’s Day
By IPP Bureau - March 12, 2025
Encourages working women to practice self-care
Syngene acquires first US biologics facility for $36.5 million
By IPP Bureau - March 11, 2025
Overall investment in the US facility is estimated around US$50 million
Emcure partners with Vidya Balan for Arth supplements,
By IPP Bureau - March 11, 2025
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
Zota Health Care launched B2C online portal ‘davaindia’
By IPP Bureau - March 11, 2025
This e-commerce platform is launched as a hyperlocal model
Glenmark Nutrition Awards 2025 celebrates innovation and impact in fight against malnutrition
By IPP Bureau - March 10, 2025
403 entries from 22 states covering 168 districts highlight groundbreaking initiatives vital to improving national nutrition metrics.
Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics
By IPP Bureau - March 10, 2025
Will add UNLOXCYT (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise
Astellas and YASKAWA to establish JV focused on cell therapy manufacturing
By IPP Bureau - March 10, 2025
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Zydus receives final approval from USFDA for Ketoconazole Shampoo, 2%
By IPP Bureau - March 10, 2025
Ketoconazole shampoo is an antifungal medication used to treat dandruff
Biocon Biologics announces positive results from Phase 3 study of Yesintek biosimilar to Ustekinumab for chronic plaque psoriasis
By IPP Bureau - March 08, 2025
The study demonstrated equivalent efficacy, safety, immunogenicity, and pharmacokinetics between YESINTEK and the reference product Stelara
Amaran Biotech signs MOU with Nippon Fine Chemical to expand CDMO business
By IPP Bureau - March 08, 2025
Amaran Biotech boasts Taiwan’s first fully automated robotic aseptic filling line, offering high-quality and low-waste filling solutions for high-value pharmaceuticals
Bionova opens Fremont process development and pilot plant
By IPP Bureau - March 07, 2025
Eris Lifesciences appoints Murari Ranganathan to drive cardiometabolic business
By IPP Bureau - March 07, 2025
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
